Clinical Trial

In January 2023, GPN Vaccines will be commencing a first-in-human clinical trial of Gamma-PN in Adelaide. For this study we are looking for 117 participants between the ages of 50 and 69 years who are in good health. To register your interest in participating, please use the link below.





Protecting children and adults from the world’s foremost bacterial pathogen